Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue

hematologic malignancy

Identifier: CI-CAN-00005254
Entity page: /cancer/extranodal-marginal-zone-lymphoma-of-mucosa-associated-lymphoid-tissue ↗
Edges: 273

Neighbours: 36 drugs10 trials
Drawn: 46 of 46 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue investigated for …INVESTIGATED_FOR33 of 33show fewer
← investigated for	Vincristinesmall_molecule	unknown	3	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	1	Curated	chembl	graph →
← investigated for	Rituximab

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 71show all (up to 200)
→ investigated in trials for	Rituximabmonoclonal_antibody 36 trials (4 active) · roll-up of the cancer and its descendants	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	36	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall_molecule 22 trials (1 active) · roll-up of the cancer and its descendants	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	22	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamidesmall_molecule 17 trials (1 active) · roll-up of the cancer and its descendants	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	17	Observed	clinicaltrials	graph →
→ investigated in trials for	Bortezomibsmall_molecule 11 trials (0 active) · roll-up of the cancer and its descendants	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenalidomidesmall_molecule 11 trials (0 active) · roll-up of the cancer and its descendants	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Etoposidesmall_molecule 8 trials (0 active) · roll-up of the cancer and its descendants	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Busulfansmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Vorinostatsmall_molecule 7 trials (0 active) · roll-up of the cancer and its descendants	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Bendamustinesmall_molecule 6 trials (2 active) · roll-up of the cancer and its descendants	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Filgrastimother 6 trials (0 active) · roll-up of the cancer and its descendants	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Dexamethasonesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Tanespimycinsmall_molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Melphalansmall_molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Methotrexatesmall_molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	4	Observed	clinicaltrials	graph →

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 71show all (up to 200)

→ investigated in trials for

Rituximabmonoclonal_antibody

36 trials (4 active) · roll-up of the cancer and its descendants

—

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue

Observed

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue studied in …STUDIED_INderived10 of 169show all (up to 200)
→ studied in	NCT07583810Phase 2 · recruiting Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma · condition mapped ALIAS · 169 trials mapped (24 active)	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	1	Observed	clinicaltrials	graph →
→ studied in	NCT06454149recruiting Cohort Study for Gastric MALT Lymphoma · condition mapped ALIAS · 169 trials mapped (24 active)	—	—	Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07101328Phase 1 · recruiting A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 ) · condition mapped ALIAS · 169 trials mapped (24 active)	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	1	Observed	clinicaltrials	graph →
→ studied in	NCT06647732Phase 2 · active not recruiting Zanubrutinib Plus Rituximab as Front-line Treatment for Mucosa-associated Lymphoid Tissue Lymphoma (MALT) · condition mapped ALIAS · 169 trials mapped (24 active)	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	1	Observed	clinicaltrials	graph →
→ studied in	NCT01479842Phase 1 · active not recruiting Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma · condition mapped ALIAS · 169 trials mapped (24 active)	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	1	Observed	clinicaltrials	graph →
→ studied in	NCT02494700Phase 2 · active not recruiting Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 169 trials mapped (24 active)	—	—	Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07705308Phase 2 · not yet recruiting A Prospective Study of Response-adapted Low-dose Radiotherapy Combined With Orelabrutinib for Localized Mucosa-associated Lymphoid Tissue Extranodal Marginal Zone Lymphoma · condition mapped ALIAS · 169 trials mapped (24 active)	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	1	Observed	clinicaltrials	graph →
→ studied in	NCT07638722Phase 2 · not yet recruiting Testing Mosunetuzumab Alone, With Zanubrutinib, or With Polatuzumab Vedotin for Treating Marginal Zone Lymphoma That Came Back or Didn't Get Better With Treatment · condition mapped CURATED_BROADER · 169 trials mapped (24 active)	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	1	Observed	clinicaltrials	graph →
→ studied in	NCT02339922Phase 2 · active not recruiting Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 169 trials mapped (24 active)	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	1	Observed	clinicaltrials	graph →
→ studied in	NCT01815749Phase 1 · active not recruiting Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma · condition mapped ALIAS · 169 trials mapped (24 active)	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains